We were proud to see our CEO & CSO, Kevin Maskell, take the stage to share how we are mining the genomes of viruses to supercharge cancer immunotherapy.

BioTrinity continues to be a fantastic platform for connecting with like-minded innovators, investors, and collaborators across the biotech ecosystem. Thanks to everyone who stopped by, shared ideas, and made this year’s event such a success.

If you missed the presentation and want to learn more about our work, drop us a message—we're always open to partnerships and conversations that push the science forward.